Cite

HARVARD Citation

    Tobin, R. et al. (2017). The clinical evidence for targeting human myeloid‐derived suppressor cells in cancer patients. Journal of leukocyte biology. 102 (2), pp. 381-391. [Online]. 
  
Back to record